BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37327965)

  • 1. Albendazole - Ivermectin combination decreases inflammation in experimental neurocysticercosis.
    da Silva Santana RC; Prudente TP; de Sousa Guerra CH; de Lima NF; de Souza Lino Junior R; Vinaud MC
    Exp Parasitol; 2023 Aug; 251():108568. PubMed ID: 37327965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic evaluation of experimental murine neurocysticercosis after treatment with albendazole/nitazoxanide combination.
    Sampaio GA; Zago LV; de Lima NF; Picanço GA; Lino Júnior RS; Vinaud MC
    Parasitology; 2020 Jun; 147(7):822-827. PubMed ID: 32234089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxfendazole induces protein catabolism and gluconeogenesis in experimental neurocysticercosis.
    Correia LTB; de Lima NF; Gomes TC; De Sousa Guerra CH; Costa TL; Vinaud MC
    Acta Trop; 2022 Oct; 234():106571. PubMed ID: 35752205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dexamethasone on albendazole cysticidal activity in experimental cysticercosis by Taenia crassiceps in BALB/c mice: In vitro and in vivo evaluation.
    Palomares-Alonso F; Toledo A; Palencia Hernández G; Jung-Cook H; Fleury A
    Exp Parasitol; 2020 Jan; 208():107801. PubMed ID: 31730781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxfendazole Nitazoxanide combination in experimental neurocysticercosis - Anti-inflammatory and cysticidal effects.
    Araújo JAA; Gomes TC; Lima VCN; Silva YBD; Lino Junior RS; Vinaud MC
    Exp Parasitol; 2024 Jul; 262():108764. PubMed ID: 38677580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial reverse of the TCA cycle is enhanced in Taenia crassiceps experimental neurocysticercosis after in vivo treatment with anthelminthic drugs.
    de Almeida Leandro L; Fraga CM; de Souza Lino R; Vinaud MC
    Parasitol Res; 2014 Apr; 113(4):1313-7. PubMed ID: 24481905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy assessment of the albendazole-ivermectin combination in lambs parasitized with resistant nematodes.
    Entrocasso C; Alvarez L; Manazza J; Lifschitz A; Borda B; Virkel G; Mottier L; Lanusse C
    Vet Parasitol; 2008 Aug; 155(3-4):249-56. PubMed ID: 18571329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial inhibition of the main energetic pathways and its metabolic consequences after
    Picanço GA; de Lima NF; Gomes TC; Fraga CM; Alves DSMM; Castillo R; da Costa TL; Lino-Junior RS; Ambrosio J; Vinaud MC
    Parasitology; 2019 Oct; 146(12):1578-1582. PubMed ID: 31303189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could ivermectin have a synergic effect with albendazole in hydatidosis therapy?
    Casado N; Moreno MJ; Urrea-París MA; Rodríguez-Caabeiro F
    Parasitol Res; 2002 Feb; 88(2):153-9. PubMed ID: 11936505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal and intracranial experimental cysticercosis present different metabolic preferences after treatment with isolated or combined albendazole and nitazoxanide.
    de Andrade Picanço G; Ferreira de Lima N; Cristina Gomes T; de Sousa Mendes Moreira Alves D; Luísa da Costa T; Vinaud MC
    Acta Trop; 2022 Feb; 226():106264. PubMed ID: 34919953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion molecules, chemokines and matrix metallo-proteinases response after albendazole and albendazole plus steroid therapy in swine neurocysticercosis.
    Singh SK; Prasad KN; Singh AK; Gupta KK; Singh A; Tripathi M; Gupta RK
    Exp Parasitol; 2017 Nov; 182():1-8. PubMed ID: 28821422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population genetics of concurrent selection with albendazole and ivermectin or diethylcarbamazine on the possible spread of albendazole resistance in Wuchereria bancrofti.
    Schwab AE; Churcher TS; Schwab AJ; Basáñez MG; Prichard RK
    Parasitology; 2006 Nov; 133(Pt 5):589-601. PubMed ID: 16834821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs.
    Alvarez L; Lifschitz A; Entrocasso C; Manazza J; Mottier L; Borda B; Virkel G; Lanusse C
    J Vet Pharmacol Ther; 2008 Jun; 31(3):230-9. PubMed ID: 18471144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel.
    Palomares-Alonso F; Palencia Hernández G; Rojas-Tomé IS; Jung-Cook H; Pinzón-Estrada E
    Exp Parasitol; 2015 Feb; 149():1-6. PubMed ID: 25500213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of pharmacological interactions after administration of a levamisole, albendazole and ivermectin triple combination in lambs.
    Suarez G; Alvarez L; Castells D; Moreno L; Fagiolino P; Lanusse C
    Vet Parasitol; 2014 Mar; 201(1-2):110-9. PubMed ID: 24462508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.
    Garcia HH; Lescano AG; Gonzales I; Bustos JA; Pretell EJ; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
    Clin Infect Dis; 2016 Jun; 62(11):1375-9. PubMed ID: 26984901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do albendazole-loaded lipid nanocapsules enhance the bioavailability of albendazole in the brain of healthy mice?
    Fabbri J; Espinosa JP; Pensel PE; Medici SK; Gamboa GU; Benoit JP; Elissondo MC
    Acta Trop; 2020 Jan; 201():105215. PubMed ID: 31600525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation Caused by Praziquantel Treatment Depends on the Location of the Taenia solium Cysticercus in Porcine Neurocysticercosis.
    Cangalaya C; Zimic M; Marzal M; González AE; Guerra-Giraldez C; Mahanty S; Nash TE; García HH;
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004207. PubMed ID: 26658257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.
    Garcia HH; Lescano AG; Lanchote VL; Pretell EJ; Gonzales I; Bustos JA; Takayanagui OM; Bonato PS; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
    Br J Clin Pharmacol; 2011 Jul; 72(1):77-84. PubMed ID: 21332573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Ivermectin in Neurocysticercosis: A Case Report.
    Samannodi MS; Zhao A; Hasbun R
    Am J Case Rep; 2018 Nov; 19():1378-1381. PubMed ID: 30455413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.